How a Former Wallstreetbets Mod Secretly Turned NKTR into a 178% Goldmine—And You’ll Never Guess What’s Next!

Few retail analysts can match the résumé of Grandmaster-OBI—former WallStreetBets moderator and lead strategist of the Making Easy Money Stock Market Alert Server on Discord. His latest triumph: flagging Nektar Therapeutics (NKTR.US) at $9.69 on June 23, 2024, and watching it explode to $26.97 on June 24 2025. That one call handed followers a swift 178 % return, turning every $1 k into roughly $2,780.

178 % in 12 Months: The Trade Math

Return: ((26.97 – 9.69) ÷ 9.69) × 100 ≈ 178 %

A $1,000 position placed at Grandmaster-OBI’s alert has ballooned to roughly $2,780—all from a single swing.

Why NKTR Exploded—and Why It Could Run Again

1. Blockbuster Trial Read-Out (Live Data)
Late yesterday, Nektar announced that its phase 2b study of rezpegaldesleukin in atopic dermatitis met the primary endpoint (mean EASI score) across all three dose arms versus placebo. Key secondary endpoints—itch relief and quality-of-life measures—also hit statistical significance at week 16.

2. Regulatory Tailwind

• The FDA granted Fast Track status to rezpegaldesleukin in February for moderate-to-severe atopic dermatitis in patients aged ≥ 12.

• Chief Executive Howard Robin confirmed top-line data for the drug’s alopecia-areata trial are slated for Q4 2025, adding another catalyst to the calendar.

3. Classic Grandmaster-OBI Setup

• Tight Float: Limited tradable shares meant every hedge-driven buy order punched above its weight.

• Options Ignition: Call open interest spiked the moment trial chatter surfaced, forcing market makers to delta-hedge by buying shares—kick-starting a gamma squeeze.

• Short-Cover Pressure: Borrow fees climbed over 20 % APR, making life miserable for shorts as price momentum accelerated.

A Resume of Moonshots

NKTR is only the latest addition to Grandmaster-OBI’s highlight reel:

*post-split equivalent

Each alert dropped in real time inside Making Easy Money, complete with screenshots, borrow-rate tables, and options heat maps—long before institutional research desks reacted.

Inside the Making Easy Money Edge

• Instant Signals: Trade ideas are posted the moment catalysts break.

• Live Voice Rooms: Members hash out entries and exits as order flow prints.

• Data Dashboards: Short-interest trackers, gamma-exposure charts, and borrow-cost gauges update continuously.

It’s a formula that lets retail traders act with the speed—and often the accuracy—of quant funds.

What to Watch Next

1. Alopecia Areata Results (Q4 2025). A positive read-out could propel NKTR into new territory.

2. Analyst Upgrades. Street price targets remain far below current momentum; any rerating could draw fresh money.

3. Options Flow. Sustained call buying near the $30-$35 strikes would signal dealers are once again being squeezed higher.

Bottom Line
Grandmaster-OBI’s $9.69 NKTR alert has already minted a 178 % gain—with FDA fast-track status and another clinical catalyst on deck. For traders plugged into his real-time Discord feed, the next life-changing move might be just one alert away.

Past performance is not a guarantee of future results. This article is for informational purposes only and does not constitute financial advice.